Parkinsonism in multiple system atrophy: Natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease

Movement Disorders

Volumn 17, Issue 4, 2002, Pages 701-709

  Tison, François ^a,d   Yekhlef, Farid ^a   Chrysostome, Virginie ^a   Balestre, Eric ^a   Quinn, Niall P ^b   Poewe, Werner ^c   Wenning, Gregor K ^c  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^d HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Dependency; Factor analysis; Internal consistency; Multiple system atrophy; Parkinson's disease; Parkinsonism; Severity; UPDRS III

Indexed keywords

LEVODOPA; ANTIPARKINSON AGENT;

ARTICLE; BRADYKINESIA; CEREBELLUM DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; DISEASE SEVERITY; FACTORIAL ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RIGIDITY; SHY DRAGER SYNDROME; STRUCTURE ANALYSIS; TIME SERIES ANALYSIS; TREMOR; AGED; CLASSIFICATION; DAILY LIFE ACTIVITY; DISABILITY; DRUG EFFECT; FEMALE; MALE; MENTAL HEALTH; MIDDLE AGED; NEUROLOGIC EXAMINATION; REPRODUCIBILITY; STATISTICS;

ACTIVITIES OF DAILY LIVING; AGED; ANTIPARKINSON AGENTS; DISABILITY EVALUATION; FEMALE; HUMANS; LEVODOPA; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NEUROLOGIC EXAMINATION; PARKINSONIAN DISORDERS; REPRODUCIBILITY OF RESULTS;

EID: 0036651239     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10171     Document Type: Article

References (39)

1. Quinn NP. Multiple system atrophy - the nature of the beast. J Neurol Neurosurg Psychiatry 1989;(Suppl.):78-89.
2. Quinn NP. Multiple system atrophy. In: Marsden CD, Fahn S, editors. Movement disorders III. London: Butterworth Heinemann; 1994. p 262-281.
3. Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy: an analysis of 100 cases. Brain 1994;117:835-846.
4. Wenning GK, Tison F, Ben Shlomo, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997;12:133-147.
5. Litvan I, Goetz CG, Jankovic J, et al. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathological study. Arch Neurol 1997;54:937-944.
6. Wenning GK, Tison F, Elliot L, Quinn NP, Daniel SE. Olivopontocerebellar pathology in multiple system atrophy. Mov Disord 1996;11:157-162.
7. Tison F, Wenning GK, Daniel SE, Quinn NP. The pathophysiology of parkinsonism in multiple system atrophy. Eur J Neurol 1995;2:435-444.
8. Lantos PL, Papp MI. Cellular pathology of multiple system atrophy: a review. J Neurol Neurosurg Psychiatry 1994;57:129-133.
9. Lantos PL. The definition of multiple system atrophy: a review of recent developments. J Neuropathol Exp Neurol 1998;57:1099-1111.
10. Gilman S, Low PA, Quinn NP, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98.
11. Litvan I, Booth V, Wenning GK, et al. Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy. J Neural Transm 1998;105:217-227.
12. Quinn NP, Marsden CD. The motor disorder of multiple system atrophy. J Neurol Neurosurg Psychiatry 1993;56:1239-1242.
13. Albanese A, Colosimo C, Bentivoglio AR, Fenici R, Melillo G, Colosimo C, Tonali P. Multiple system atrophy presenting as parkinsonism: clinical features and diagnosis criteria. J Neurol Neurosurg Psychiatry 1995;59:144-151.
14. Goudier-Khouja N, Vidailhet M, Bonnet AM, Pichon J, Agid Y. "Pure" striatonigral degeneration and Parkinson's disease: a comparative clinical study. Mov Disord 1995;10:288-294.
15. Stebbins GT, Goetz CG. Factor structure of the Unified Parkinson's Disease Rating Scale: motor examination section. Mov Disord 1998;13:633-636.
16. McRae C, Diem G, VO A, O'Brien C, Seeberger L. Schwab and Ensland: standardization of administration. Mov Disord 2000;15:335-336.
17. Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist 1970;10:20-30.
18. Lawton MP, Brodie EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
19. Schrag A, Kingsley D, Phatouros C, Mathias CJ, Lees AJ, Daniel SE, Quinn NP. Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry 1998;65:65-71.
20. Tison F, Arne P, Sourgen C, Chrysostome V, Yekhlef F. The value of external anal sphincter electromyography for the diagnosis of multiple system atrophy. Mov Disord 2000;15:1148-1157.
21. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
22. Tison F, Barberger-Gateau P, Dubroca B, Henry P, Dartigues JF. Dependency in Parkinson's disease: a population-based survey in nondemented elderly subjects. Mov Disord 1997;12:910-915.
23. Goetz CG, Stebbins GT, Chmura TA, Fahn S, Klawans HL, Marsden CD. Teaching tape for the motor section of the Unified Parkinson's Disease Rating Scale. Mov Disord 1995;10:263-266.
24. Trouillas P, Takayanagi T, Hallett M, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. J Neurol Sci 1997;145:205-211.
25. Bland JM, Altman DG. Crombach's alpha. BMJ 1997;314:572.
26. Cubo E, Stebbins GT, Golbe LI, Nieves A, Leurgans S, Goetz CG, Kompoliti K. Application of the Unified Parkinson's Disease Rating Scale in progressive supranuclear palsy: factor analysis of motor scale. Mov Disord 2000;15:276-279.
27. Wenning GK, Ben-Shlomo Y, Hughes A, Daniel SE, Lees A, Quinn NP. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;68:434-440.
28. Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 1995;58:160-166.
29. Wenning GK, Quinn NP. Multiple system atrophy. Bailliere Clin Neurol 1997;6:187-204.
30. Tison F, Yekhlef F, Chrysostome V, Sourgen C. Prevalence of multiple system atrophy. Lancet 2000;355:495-496.
31. Marchese R, Trompetto C, Buccololieri A, Abbruzzese G. Abnormalities of motor cortex excitability are not correlated with clinical features in atypical parkinsonism. Mov Disord 2000;15:1210-1214.
32. Fetoni V, Solivieri P, Monza D, Testa D, Girotti F. Affective symptoms in multiple system atrophy and Parkinson's disease: response to levodopa therapy. J Neurol Neurosurg Psychiatry 1999;66:541-544.
33. Colosimo C, Vanacore N, Bonifati V, et al. Clinical diagnosis of multiple system atrophy: level of agreement between Quinn' s criteria and the consensus conference guidelines. Acta Neurol Scand 2001;103:261-264.
34. Wenning GK, Ebersbach G, Verny M, Chaudhuri KR, Jellinger K, McKee A, Poewe W, Litvan I. Progression of falls in postmortem-confirmed parkinsonian disorders. Mov Disord 1999;14:947-950.
35. Hughes AJ, Colosimo C, Kleedorfer B, Daniel SE, Lees AJ. The dopaminergic response in multiple system atrophy. J Neurol Neurosurg Psychiatry 1992;55:1009-1013.
36. Wenning GK, Quinn NP, Daniel SE, Garratt H, Marsden CD. Facial dystonia in pathologically proven multiple system atrophy: a video report. Mov Disord 1996;11:107-109.
37. Rivest J, Quinn N, Marsden CD. Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Neurology 1990;40:1571-1578.
38. Askmark H, Eeg-Olofsson KE, Johansson A, Nilsson P, Olsson Y, Aquilonius SM. Parkinsonism and neck extensor myopathy. A new syndrome or coincidental findings? Arch Neurol 2001;58:232-237.
39. Müller J, Wenning GK, Jellinger K, McKee A, Poewe W, Litvan I. Progression of Hoehn and Yahr stages in parkinsonian disorders: a clinicopathologic study. Neurology 2000;55:888-891.